248 related articles for article (PubMed ID: 17908353)
1. Dual silencing of type 1 insulin-like growth factor and epidermal growth factor receptors to induce apoptosis of nasopharyngeal cancer cells.
Yuan YL; Zhou XH; Song J; Qiu XP; Li J; Ye LF
J Laryngol Otol; 2008 Sep; 122(9):952-60. PubMed ID: 17908353
[TBL] [Abstract][Full Text] [Related]
2. Combining siRNAs at two different sites in the EGFR to suppress its expression, induce apoptosis, and enhance 5-fluorouracil sensitivity of colon cancer cells.
Wu X; Deng Y; Wang G; Tao K
J Surg Res; 2007 Mar; 138(1):56-63. PubMed ID: 17169374
[TBL] [Abstract][Full Text] [Related]
3. Dual silencing of epidermal growth factor and insulin-like growth factor 1 receptors significantly limits growth of nasopharyngeal carcinoma in nude mice.
Zhou X; Yuan Y; Song J; Chen W; Li J; Ye L; Meng X; Xia D
J Laryngol Otol; 2009 Feb; 123(2):208-22. PubMed ID: 18452630
[TBL] [Abstract][Full Text] [Related]
4. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
5. Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells.
Riedemann J; Sohail M; Macaulay VM
Biochem Biophys Res Commun; 2007 Apr; 355(3):700-6. PubMed ID: 17320820
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of proliferation, apoptosis and senescence of nasopharyngeal cells by the simultaneously blocking EGF, IGF-1 receptors and Bcl-xl genes.
Dai G; Peng T; Zhou X; Zhu J; Kong Z; Ma L; Xiong Z; Yuan Y
Biochem Biophys Res Commun; 2013 Nov; 440(4):479-84. PubMed ID: 24055032
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus expressing shRNA to IGF-1R enhances the chemosensitivity of lung cancer cell lines by blocking IGF-1 pathway.
Lee YJ; Imsumran A; Park MY; Kwon SY; Yoon HI; Lee JH; Yoo CG; Kim YW; Han SK; Shim YS; Piao W; Yamamoto H; Adachi Y; Carbone DP; Lee CT
Lung Cancer; 2007 Mar; 55(3):279-86. PubMed ID: 17134788
[TBL] [Abstract][Full Text] [Related]
8. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53.
Niu J; Xu Z; Li XN; Han Z
Cell Biol Int; 2007 Feb; 31(2):156-64. PubMed ID: 17097318
[TBL] [Abstract][Full Text] [Related]
9. Potential role of short hairpin RNA targeting epidermal growth factor receptor in growth and sensitivity to drugs of human lung adenocarcinoma cells.
Bai L; Zhu R; Chen Z; Gao L; Zhang X; Wang X; Bai C
Biochem Pharmacol; 2006 Apr; 71(8):1265-71. PubMed ID: 16442503
[TBL] [Abstract][Full Text] [Related]
10. [Suppression of insulin-like growth factor-1 receptor by RNA interference inhibits cell growth in vitro and induces chemosensitization of HO8910PM cell to cisplatin].
Gao H; Shi J; Ge SF; DI W
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):45-9. PubMed ID: 18366933
[TBL] [Abstract][Full Text] [Related]
11. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells.
Fang J; Zhou Q; Shi XL; Jiang BH
Carcinogenesis; 2007 Mar; 28(3):713-23. PubMed ID: 17065200
[TBL] [Abstract][Full Text] [Related]
12. Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: a novel approach for overcoming resistance in anticancer treatment.
Tandon R; Kapoor S; Vali S; Senthil V; Nithya D; Venkataramanan R; Sharma A; Talwadkar A; Ray A; Bhatnagar PK; Dastidar SG
Eur J Pharmacol; 2011 Sep; 667(1-3):56-65. PubMed ID: 21640718
[TBL] [Abstract][Full Text] [Related]
13. Co-inhibition of epidermal growth factor receptor and type 1 insulin-like growth factor receptor synergistically sensitizes human malignant glioma cells to CD95L-induced apoptosis.
Steinbach JP; Eisenmann C; Klumpp A; Weller M
Biochem Biophys Res Commun; 2004 Aug; 321(3):524-30. PubMed ID: 15358139
[TBL] [Abstract][Full Text] [Related]
14. SiRNA-mediated IGF-1R inhibition sensitizes human colon cancer SW480 cells to radiation.
Yavari K; Taghikhani M; Maragheh MG; Mesbah-Namin SA; Babaei MH; Arfaee AJ; Madani H; Mirzaei HR
Acta Oncol; 2010; 49(1):70-5. PubMed ID: 20001499
[TBL] [Abstract][Full Text] [Related]
15. The EGF receptor interacts with the type 1 IGF receptor and regulates its stability.
Riedemann J; Takiguchi M; Sohail M; Macaulay VM
Biochem Biophys Res Commun; 2007 Apr; 355(3):707-14. PubMed ID: 17307140
[TBL] [Abstract][Full Text] [Related]
16. [Double sites short hairpin RNAs targeting epidermal growth factor receptor to promote colon cancer cells apoptosis and enhance 5-fluorouracil chemotherapy effect].
Wu XB; Tao KX; Wang GB; Tian Y; Zhang JH; Chen DD
Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):765-9. PubMed ID: 16836928
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
[TBL] [Abstract][Full Text] [Related]
18. The IGF receptor as anticancer treatment target.
Macaulay VM
Novartis Found Symp; 2004; 262():235-43; discussion 243-6, 265-8. PubMed ID: 15562833
[TBL] [Abstract][Full Text] [Related]
19. Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity.
Sun HZ; Wu SF; Tu ZH
Cell Res; 2001 Jun; 11(2):107-15. PubMed ID: 11453542
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
